Lynn A. Tetrault
Director · 5 filings · Latest: Jun 23, 2026
NEOGENOMICS INC
RHYTHM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Lynn A. Tetrault | Director | Jun 23, 2026 | Option Exercise | — | 4,712 | — | 11,712 | |
RYTM | Lynn A. Tetrault | Director | Jun 22, 2026 | Sale | $100.32 | 37,000 | $3.7M | 7,000 | |
RYTM | Lynn A. Tetrault | Director | Jun 22, 2026 | Option Exercise | $28.27 | 37,000 | $1.0M | 44,000 | |
RYTM | LYNN TETRAULT | — | Jun 22, 2026 | Proposed Sale | $96.79 | 37,000 | $3.6M | — | |
NEO | Lynn A. Tetrault | Director | Jun 15, 2026 | Sale | $11.10 | 5,307 | $58.9K | 86,115 | |
NEO | LYNN TETRAULT | — | Jun 15, 2026 | Proposed Sale | $11.15 | 5,307 | $59.2K | — | |
NEO | Lynn A. Tetrault | Director | Jun 9, 2026 | Sale | $11.29 | 5,307 | $59.9K | 91,422 | |
NEO | LYNN TETRAULT | — | Jun 9, 2026 | Proposed Sale | $10.95 | 5,307 | $58.1K | — | |
NEO | Lynn A. Tetrault | Director | Jun 1, 2026 | Option Exercise | $0.00 | 23,077 | — | 96,729 | |
RYTM | LYNN TETRAULT393 COMMONWEALTH AVE | — | Sep 10, 2024 | Proposed Sale | $50.66 | 17,501 | $886.6K | — | |
RYTM | LYNN TETRAULT393 COMMONWEALTH AVE | — | Aug 26, 2024 | Proposed Sale | $46.12 | 7,499 | $345.9K | — |